financetom
Business
financetom
/
Business
/
Market Chatter: RBC's Head of Canadian Research Leaves For TD
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: RBC's Head of Canadian Research Leaves For TD
Mar 27, 2024 12:43 PM

03:28 PM EDT, 03/27/2024 (MT Newswires) -- Andre-Philippe Hardy has returned to the bank where his career began, The Globe and Mail is reporting Wednesday.

After nearly 17 years at Royal Bank of Canada ( RY ), most recently as head of Canadian and Asia-Pacific research, Hardy rejoined Toronto-Dominion Bank ( MLWIQXX ) earlier this month as head of Canadian research. His new responsibilities are expected to involve merging TD's Canadian research offerings with those of Cowen Inc., the New York-based independent investment bank that TD acquired for US$1.3-billion in 2022.

"I know from past conversations with TD bankers that their priority is integrating the TD Securities' Canadian platform with Cowen's U.S. platform," said Bill Vlaad, the chief executive officer of Toronto-based executive search firm Vlaad and Co. "And RBC runs an integrated global equity research platform, which Andre-Philippe helped create and manage."

TD Securities spokesperson Jillian Tanouye confirmed via e-mail that Hardy had recently started in his new role, adding that he will be reporting to global head of research Robert Fagin. Hardy's appointment represents the latest in a number of personnel changes TD has made in the wake of the Cowen deal.

Sante Corona was promoted to co-head of TD's global equity capital markets business in March, 2023, and relocated to New York two months later to create "seamless connectivity" between TD and Cowen, the bank said at the time. In December, 2023, as TD was preparing to cut roughly 3,000 jobs, the bank announced nearly a dozen new hires for its investment banking, equity sales and research teams in order to expedite its U.S. expansion plans.

(Market Chatter news is derived from conversations with market professionals globally, and/or from other media sources. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 81.92, Change: +0.88, Percent Change: +1.09

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Iraq to sign agreement with US company Excelerate Energy to supply gas to Iraq, prime minister's office says
Iraq to sign agreement with US company Excelerate Energy to supply gas to Iraq, prime minister's office says
Oct 20, 2025
CAIRO, Oct 20 (Reuters) - Iraq will sign an agreement with U.S.-based LNG company Excelerate Energy ( EE ) to supply U.S. gas to Iraq, the Iraqi prime minister's office said on Monday without providing further details. ...
Apple nears $4 trillion valuation as shares surge on strong iPhone 17 demand
Apple nears $4 trillion valuation as shares surge on strong iPhone 17 demand
Oct 20, 2025
(Reuters) -Apple shares surged to an all-time high on Monday, with the iPhone maker close to becoming the third company to hit a $4 trillion market valuation as data showed strong momentum for the latest iPhone. Data from research firm Counterpoint showed the iPhone 17 series outperformed its predecessor in early sales in China and the United States, with the...
Planet 13 Holdings Opens New Dispensary in Pace, Florida
Planet 13 Holdings Opens New Dispensary in Pace, Florida
Oct 20, 2025
01:29 PM EDT, 10/20/2025 (MT Newswires) -- Planet 13 Holdings ( PLNH ) on Monday said it opened its newest cannabis dispensary in Pace, Florida. The company said the dispensary is located along a busy retail corridor directly across from a Walmart and Lowe's. Pace is one of the fastest-growing communities in the Florida Panhandle, the company said. Planet 13...
Kenvue Asks FDA to Deny Citizen Petition for Autism Warning on Tylenol
Kenvue Asks FDA to Deny Citizen Petition for Autism Warning on Tylenol
Oct 20, 2025
12:59 PM EDT, 10/20/2025 (MT Newswires) -- Kenvue ( KVUE ) said Sunday it urged the US Food and Drug Administration to reject a citizen petition for an autism warning on Tylenol, the over-the-counter drug to treat pain and reduce fever, including during pregnancy. The drugmaker said the petition for labeling changes should be denied because there is no causal...
Copyright 2023-2026 - www.financetom.com All Rights Reserved